United States· US:67877-929_8617bd03-6da7-48ca-b430-6dfc38f19e2b
MYCOPHENOLIC ACID
A medicinal product containing mycophenolate sodium, registered in United States by Ascend Laboratories, LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- MYCOPHENOLATE SODIUM
- Manufacturer
- Ascend Laboratories, LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc1167877-929-05
- ndc1167877-929-12
- ndc1167877-929-38
- ndc116787792905500 TABLET, DELAYED RELEASE in 1 BOTTLE (67877-929-05)
- ndc116787792912120 TABLET, DELAYED RELEASE in 1 BOTTLE (67877-929-12)
- ndc11678779293810 BLISTER PACK in 1 CARTON (67877-929-38) / 10 TABLET, DELAYED RELEASE in 1 BLISTER PACK (67877-929-33)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mycophenolate sodium in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaMYCOPHENOLIC ACID ACCORDACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- BelgiumAccempa 360 mgTeva Pharma Belgium
- FinlandMyastadSTADA Arzneimittel AG
- IrelandMyfortic 360 mg gastro-resistant tabletsPCO Manufacturing Ltd.
- GermanyMycophenolsäure HexalHexal Ag
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Germany · Mycophenolsäure Hexal
- Spain · Ceptava
- Italy · Ceptava
- Portugal · Ácido Micofenólico Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b30456df-3346-4472-a480-55cd9a5cb9ff GET /v1/drugs/b30456df-3346-4472-a480-55cd9a5cb9ff?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "360",
"substance": "MYCOPHENOLATE SODIUM",
"productndc": "67877-929",
"dosage_form": "TABLET, DELAYED RELEASE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA208315",
"marketing_category": "ANDA"
}See everything about mycophenolate sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.